Skip to main content

BANK OF AMERICA CORP /DE/

Bank

Position in DNA — Ginkgo Bioworks Holdings, Inc.

CIK 70858 CHARLOTTE, NC

Position in DNA

as of Mar 31, 2026 · filed May 18, 2026
Position Value
$2,923,476
-$2,083,928 QoQ
Shares Held
476,913
-20.9% QoQ
Ownership
0.730%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in DNA Over Time

Shares Held

Position Value (USD)

Derivatives in DNA

reported options exposure · as of Sep 30, 2025
CallValue
$338,256
CallShares
23,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. DNA ranks #155 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DNA

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,923,476 476,913
2025-12-31 $5,007,404 602,576
2025-09-30 $338,256 23,200
2025-09-30 $15,579,821 1,068,575
2025-06-30 $78,750 7,000
2025-06-30 $13,580,403 1,207,147
2025-06-30 $261,000 23,200
2025-03-31 $5,741,803 1,007,334
2025-03-31 $231,990 40,700
2024-12-31 $36,966,946 3,764,455
2024-09-30 $3,484,051 427,491